Assessing the impact of structured education on the knowledge of hospital pharmacists about adverse drug reactions and reporting methods in Saudi Arabia: an open-label randomised controlled trial
Pharmacists have limited knowledge about adverse drug reactions (ADRs) in Saudi Arabia.
The aim of this study was to assess the impact of educational intervention on the knowledge of hospital pharmacists about ADRs.
This was a 3-month randomized controlled trial conducted in Saudi Arabia between January 2018 and March 2018. Participants in both groups were required to complete an online questionnaire at baseline and at 12-week follow-up. Participants in the intervention group received a structured information sheet about ADRs 2 weeks after the first assessment. The main outcome measure was difference in mean knowledge score about ADRs.
Main outcome measure
Difference in mean knowledge score about ADRs.
A total of 46 participants were included in the study. At the 12-week follow-up, there was a significant improvement in the mean knowledge score (± standard deviation) of intervention participants from 7.67 (± 2.1) at baseline to 11.22 (± 0.4) (95% CI −4.5 to −2.5; p < 0.0001). The mean knowledge score of control participants remained unchanged at 6.71 (± 2.3) during both baseline and follow-up assessments.
ADR-specific education was associated with a significant improvement in the knowledge and understanding of pharmacists about ADRs and their methods of reporting.
We would like to thank all individuals who participated in the study.
Compliance with ethical standards
The study was approved by the Institutional Review Board of Umm-al-Qura University (UQU-COP-EA# 143630).
Conflict of interest
The authors declare no relevant conflicts of interest
This study did not receive any funding.
Participants were provided written information about the study and its aims. The completion and submission of the anonymised online questionnaire by the participants was taken as their consent to the study.
- 2.Vereen JC, Weiss M. Trends in emergency hospital admissions in England due to adverse drug reactions: 2008–2015. JPHS. 2017;8:5–11.Google Scholar
- 4.MHRA. Adverse Drug Reactions. http://www.mhra.gov.uk/Safetyinformation/Howwemonitorthesafetyofproducts/Medicines/TheYellowCardScheme/Informationforhealthcareprofessionals/Adversedrugreactions/index.htm. Accessed 01 October 2018.Google Scholar
- 7.Al Doughan FF, Alomi YA, Iflaifel MH. Pharmacist’s awareness and knowledge of reporting adverse drug reactions in Saudi Arabia. Int J Pharm Health Sci. 2019;2:60–5.Google Scholar